Yoriko Yamashita-Kashima

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Chronic Lymphocytic Leukemia

Top Venues

Leukemia & lymphoma

Molecular biology reports

International journal of hematology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Natsumi Kawasaki, Mayu Tomita, Yoriko Yamashita-Kashima, Yasushi Yoshimura, Shigeki Yoshiura
Efficacy of retreatment with polatuzumab vedotin in combination with rituximab in polatuzumab vedotin-resistant DLBCL models. Leukemia & lymphoma (2023)
Natsumi Kawasaki, Yoriko Yamashita-Kashima, Takaaki Fujimura, Shigeki Yoshiura, Naoki Harada, Osamu Kondoh, Yasushi Yoshimura
Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapies. Molecular biology reports 49 (6) (2022)
Yoriko Yamashita-Kashima, Keigo Yorozu, Takaaki Fujimura, Natsumi Kawasaki, Mitsue Kurasawa, Shigeki Yoshiura, Naoki Harada, Osamu Kondoh, Yasushi Yoshimura
Coadministration with bendamustine restores the antitumor activity of obinutuzumab in obinutuzumab-resistant tumors. International journal of hematology 115 (6) (2022)
Takaaki Fujimura, Yoriko Yamashita-Kashima, Natsumi Kawasaki, Shigeki Yoshiura, Naoki Harada, Yasushi Yoshimura
Obinutuzumab in Combination with Chemotherapy Enhances Direct Cell Death in CD20-Positive Obinutuzumab-resistant Non-Hodgkin Lymphoma Cells. Molecular cancer therapeutics 20 (6) (2021)